Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model.

Journal: International urology and nephrology
Published Date:

Abstract

PURPOSE: We aimed to assess the appropriateness of ChatGPT in providing answers related to prostate cancer (PCa) screening, comparing GPT-3.5 and GPT-4.

Authors

  • Giuseppe Chiarelli
    VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
  • Alex Stephens
    Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
  • Marco Finati
    VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
  • Giuseppe Ottone Cirulli
    VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
  • Edoardo Beatrici
    Department of Urology, IRCCS - Humanitas Research Hospital, Milan, Italy; Department of Biomedical Science, Humanitas University, Milan, Italy.
  • Dejan K Filipas
    Division of Urological Surgery and Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Sohrab Arora
    1 Vattikuti Urology Institute , Henry Ford Hospital, Detroit, Michigan.
  • Shane Tinsley
    VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
  • Mahendra Bhandari
  • Giuseppe Carrieri
    Urology and Renal Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
  • Quoc-Dien Trinh
    Department of Surgery, Division of Urology, Dana Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Alberto Briganti
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Francesco Montorsi
    Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, URI, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132, Milan, Italy.
  • Giovanni Lughezzani
    Humanitas Clinical and Research Center-IRCCS, Department of Urology, Rozzano, Italy.
  • Nicolò Buffi
    Department of Urology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
  • Craig Rogers
    Department of Urology, Henry Ford Health System, Detroit, MI, USA.
  • Firas Abdollah
    Vattikuti Urology Institute, Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.